3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino]propionic acid ethyl ester
![BK6E43 | 211915-84-3 | 3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino]propionic acid ethyl ester](https://qncdn.chemcd.cn/alchemypharm/AP10036.png "BK6E43 | 211915-84-3 | 3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino]propionic acid ethyl ester")
Catalog No.: BK6E43
CAS.RN：211915-84-3
Molecular Formula: C27H26N6O3
Molecular Weight: 482.53 g/mol
Purity: NLT 98%
Intermediates of Dabigatran etexilate
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA028Z | Dabigatran etexilate API | 211915-06-9 |
| BK85D7 | 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester | 212322-56-0 |
| BK6E43 | 3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino]propionic acid ethyl ester | 211915-84-3 |
| BK559K | N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | 211914-50-0 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
